Literature DB >> 16639500

Parkinson's disease: a rethink of rodent models.

Heather L Melrose1, Sarah J Lincoln, Glenn M Tyndall, Matthew J Farrer.   

Abstract

Parkinson's disease (PD) is a multifactorial disease with a complex etiology that results from genetic risk factors, environmental exposures and most likely a combination of both. Rodent models of parkinsonism aim to reproduce key pathogenic features of the syndrome including movement disorder induced by the progressive loss of dopaminergic neurons in the substantia nigra, accompanied by the formation of alpha-synuclein containing Lewy body inclusions. Despite the creation of many excellent models, both chemically induced and genetically engineered, there is none that accurately demonstrates these features. Recent pathological staging studies in man have also emphasized the significant non-CNS component of PD that has yet to be tackled. Herein, we summarize rodent models of PD and what they offer to the field, and suggest future challenges and opportunities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639500     DOI: 10.1007/s00221-006-0461-3

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  97 in total

1.  Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine.

Authors:  N G Kholodilov; T F Oo; R E Burke
Journal:  Neurosci Lett       Date:  1999-11-12       Impact factor: 3.046

2.  Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.

Authors:  Y Matsuoka; M Vila; S Lincoln; A McCormack; M Picciano; J LaFrancois; X Yu; D Dickson; W J Langston; E McGowan; M Farrer; J Hardy; K Duff; S Przedborski; D A Di Monte
Journal:  Neurobiol Dis       Date:  2001-06       Impact factor: 5.996

3.  Mice lacking alpha-synuclein are resistant to mitochondrial toxins.

Authors:  Peter Klivenyi; Donald Siwek; Gabrielle Gardian; Lichuan Yang; Anatoly Starkov; Carine Cleren; Robert J Ferrante; Neil W Kowall; Asa Abeliovich; M Flint Beal
Journal:  Neurobiol Dis       Date:  2005-11-18       Impact factor: 5.996

4.  Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.

Authors:  Denise M Kay; Patricia Kramer; Don Higgins; Cyrus P Zabetian; Haydeh Payami
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

5.  Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.

Authors:  P J Kahle; M Neumann; L Ozmen; V Muller; H Jacobsen; A Schindzielorz; M Okochi; U Leimer; H van Der Putten; A Probst; E Kremmer; H A Kretzschmar; C Haass
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

6.  The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein.

Authors:  Amy B Manning-Bog; Alison L McCormack; Jie Li; Vladimir N Uversky; Anthony L Fink; Donato A Di Monte
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

Review 7.  Alpha-synuclein and transgenic mouse models.

Authors:  Pierre-Olivier Fernagut; Marie-Françoise Chesselet
Journal:  Neurobiol Dis       Date:  2004-11       Impact factor: 5.996

8.  Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.

Authors:  Suzana Gispert; Domenico Del Turco; Lisa Garrett; Amy Chen; David J Bernard; John Hamm-Clement; Horst-Werner Korf; Thomas Deller; Heiko Braak; Georg Auburger; Robert L Nussbaum
Journal:  Mol Cell Neurosci       Date:  2003-10       Impact factor: 4.314

9.  Efficient recombination-based methods for bacterial artificial chromosome fusion and mutagenesis.

Authors:  Bryce L Sopher; Albert R La Spada
Journal:  Gene       Date:  2006-02-17       Impact factor: 3.688

10.  Developmental pesticide models of the Parkinson disease phenotype.

Authors:  Deborah A Cory-Slechta; Mona Thiruchelvam; Brian K Barlow; Eric K Richfield
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

View more
  25 in total

1.  Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance.

Authors:  Jiyong Liang; Zhi-Xiang Xu; Zhiyong Ding; Yiling Lu; Qinghua Yu; Kaitlin D Werle; Ge Zhou; Yun-Yong Park; Guang Peng; Michael J Gambello; Gordon B Mills
Journal:  Nat Commun       Date:  2015-08-14       Impact factor: 14.919

Review 2.  The pathways of mitophagy for quality control and clearance of mitochondria.

Authors:  G Ashrafi; T L Schwarz
Journal:  Cell Death Differ       Date:  2012-06-29       Impact factor: 15.828

3.  Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease.

Authors:  Kotaro Kida; Marina Yamada; Kentaro Tokuda; Eizo Marutani; Manabu Kakinohana; Masao Kaneki; Fumito Ichinose
Journal:  Antioxid Redox Signal       Date:  2011-04-05       Impact factor: 8.401

Review 4.  Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.

Authors:  Varduhi H Knaryan; Supriti Samantaray; Charlene Le Gal; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2011-06-17       Impact factor: 5.372

5.  N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse.

Authors:  Ari E Berman; Wai Yee Chan; Angela M Brennan; Reno C Reyes; Brittany L Adler; Sang Won Suh; Tiina M Kauppinen; Ylva Edling; Raymond A Swanson
Journal:  Ann Neurol       Date:  2010-11-23       Impact factor: 10.422

Review 6.  Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Authors:  Jacques Fantini; Henri Chahinian; Nouara Yahi
Journal:  Protein Sci       Date:  2020-07-13       Impact factor: 6.725

Review 7.  The genetics of Parkinson disease.

Authors:  Lynn M Bekris; Ignacio F Mata; Cyrus P Zabetian
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-10-11       Impact factor: 2.680

Review 8.  Adult neurogenesis in Parkinson's disease.

Authors:  Franz Marxreiter; Martin Regensburger; Jürgen Winkler
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

9.  Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder.

Authors:  Jennifer Barber-Singh; Byoung Boo Seo; Eiko Nakamaru-Ogiso; Yuen-Sum Lau; Akemi Matsuno-Yagi; Takao Yagi
Journal:  Rejuvenation Res       Date:  2009-08       Impact factor: 4.663

Review 10.  In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?

Authors:  Marie-Francoise Chesselet
Journal:  Exp Neurol       Date:  2007-08-23       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.